Merck (MRK) Cash from Investing Activities (2009 - 2026)

Merck (MRK) has 18 years of Cash from Investing Activities data on file, last reported at -$10.2 billion in Q1 2026.

• Cash from Investing Activities for Q1 2026 came in at -$10.2 billion, down 586.62% year-over-year; the trailing twelve-month figure through Mar 2026 was -$22.5 billion (down 186.35% YoY), and the FY2025 annual result was -$13.7 billion, down 77.67% from the prior year.
• Cash from Investing Activities grew to -$10.2 billion in Q1 2026 per MRK's latest filing, from -$11.2 billion in the prior quarter.
• Over five years, Cash from Investing Activities peaked at $53.0 million in Q4 2023 and troughed at -$11.4 billion in Q2 2023.
• A 5-year average of -$3.0 billion and a median of -$1.4 billion in 2024 frame the typical range for Cash from Investing Activities.
• The sharpest annual moves came in 2023 and 2024: Cash from Investing Activities soared 103.03% in 2023, then sank 2824.53% in 2024.
• A 5-year view of Cash from Investing Activities shows it stood at -$1.7 billion in 2022, then surged by 103.03% to $53.0 million in 2023, then slumped by 2824.53% to -$1.4 billion in 2024, then sank by 675.69% to -$11.2 billion in 2025, then grew by 8.85% to -$10.2 billion in 2026.
• Business Quant data shows MRK's Cash from Investing Activities at -$10.2 billion in Q1 2026, -$11.2 billion in Q4 2025, and -$283.0 million in Q3 2025.